Catenabio
catenabio.com
Actively hiring
Cell & Gene Therapy
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
2
Y Combinator, LongeVC
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 2021
Went through Y Combinator
Backed byfrom the funds' portfolios and accelerator catalogs
Y Combinator 
LongeVC Investors in similar startupsfunds that back the companies most like this one
backs Profluent
backs Mammoth Biosciences
backs Mammoth Biosciences
backs Mammoth Biosciences
backs Profluent
Similar startupsby what they do, their industry and backers
Lift to Zenith with Novel Myeloid Engager Therapeutics. To maximize the drugability potential, we target approaches to improve clinical…
Top of page A small team taking on a big pest problem. Developing innovative approaches to address major insect pest challenges on the farm…
Pencil Biosciences is pioneering the next generation of gene editing. We are developing a fully synthetic, RNA-guided platform designed to…
At cellvie, we are pioneering Therapeutic Mitochondria Transplantation, a novel treatment approach aimed at the cellular energy metabolism.
Profluent is a company founded in 2022 that trains large language models on protein sequences to design new functional proteins. It…
At Jaguar Gene Therapy, we believe in a world where patients and families won’t have to hear those words. Our mission is to accelerate…